We are live on ! Find out more
BHCM

Brevan Howard Capital Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 35.84%
This Fund
S&P 500
This Quarter Est. Return
+6.99%
1 Year Est. Return
+35.84%
3 Year Est. Return
+106.49%
5 Year Est. Return
+80.14%
10 Year Est. Return
–
AUM
$14.4B
AUM Growth
+$3.17B
Cap. Flow
+$1.99B
Cap. Flow %
13.87%
Top 10 Hldgs %
75.34%
Holding
1,511
New
483
Increased
305
Reduced
301
Closed
405

Top Buys

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$92.1M
2
MSFT icon
Microsoft
MSFT
+$81.2M
3
NVDA icon
NVIDIA
NVDA
+$77.3M
4
LLY icon
Eli Lilly
LLY
+$27.2M
5
SPOT icon
Spotify
SPOT
+$27.1M

Top Sells

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$59M
2
AAPL icon
Apple
AAPL
+$50.2M
3
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$33.8M
4
UNH icon
UnitedHealth
UNH
+$21.4M
5
SMCI icon
Super Micro Computer
SMCI
+$20.5M

Sector Composition

Rank Sector Weight
1 Technology 2.53%
2 Financials 2.03%
3 Industrials 1.57%
4 Healthcare 1.55%
5 Communication Services 1.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAR icon
951
Darling Ingredients
DAR
$9.99B
$222K ﹤0.01%
+5,977
New +$225K
APOG icon
952
Apogee Enterprises
APOG
$887M
$222K ﹤0.01%
+3,169
New +$204K
REYN icon
953
Reynolds Consumer Products
REYN
$5.51B
$221K ﹤0.01%
+7,121
New +$211K
NOV icon
954
NOV
NOV
$7.38B
$219K ﹤0.01%
13,708
-17,353
-56% -$308K
DFIN icon
955
Donnelley Financial Solutions
DFIN
$1.17B
$219K ﹤0.01%
3,325
-3,058
-48% -$199K
SR icon
956
Spire
SR
$4.79B
$218K ﹤0.01%
+3,238
New +$210K
AAT
957
American Assets Trust
AAT
$1.38B
$217K ﹤0.01%
+8,132
New +$206K
CDMO
958
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$217K ﹤0.01%
19,067
-23,570
-55% -$237K
ROG icon
959
Rogers Corp
ROG
$2.29B
$216K ﹤0.01%
+1,914
New +$214K
PEGA icon
960
Pegasystems
PEGA
$5.43B
$216K ﹤0.01%
5,908
-10,126
-63% -$333K
CRSP icon
961
CRISPR Therapeutics
CRSP
$5.17B
$216K ﹤0.01%
+4,595
New +$233K
ALHC icon
962
Alignment Healthcare
ALHC
$2.86B
$214K ﹤0.01%
+18,109
New +$171K
TILE icon
963
Interface
TILE
$2.18B
$213K ﹤0.01%
+11,224
New +$194K
FORM icon
964
FormFactor
FORM
$8.79B
$213K ﹤0.01%
+4,628
New +$231K
RBA icon
965
RB Global
RBA
$17.4B
$212K ﹤0.01%
+2,636
New +$214K
PYCR
966
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
$212K ﹤0.01%
+14,917
New +$198K
HEI.A icon
967
HEICO Corp Class A
HEI.A
$37B
$212K ﹤0.01%
+1,038
New +$197K
NWL icon
968
Newell Brands
NWL
$2.51B
$211K ﹤0.01%
27,527
-79,526
-74% -$570K
PCVX icon
969
Vaxcyte
PCVX
$8.67B
$211K ﹤0.01%
+1,847
New +$166K
EW icon
970
Edwards Lifesciences
EW
$53B
$208K ﹤0.01%
3,155
-27,034
-90% -$1.96M
BIIB icon
971
Biogen
BIIB
$30.6B
$208K ﹤0.01%
+1,074
New +$225K
CDNA icon
972
CareDx
CDNA
$2.44B
$208K ﹤0.01%
6,665
-29,923
-82% -$745K
WWW icon
973
Wolverine World Wide
WWW
$1.55B
$208K ﹤0.01%
+11,923
New +$165K
ACAD icon
974
Acadia Pharmaceuticals
ACAD
$5.06B
$207K ﹤0.01%
13,479
-19,857
-60% -$331K
BLKB icon
975
Blackbaud
BLKB
$2.09B
$206K ﹤0.01%
2,437
-5,215
-68% -$415K
37 38
39
40 41

Similar funds

GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
DWM
Dynasty Wealth Management St. Petersburg, Florida $11.5B AUM 15.23% 1-Year Est. Return
HTC
Haverford Trust Company Radnor, Pennsylvania $10.9B AUM 18.64% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Brevan Howard Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Brevan Howard Capital Management held 1,511 positions worth $14.4B, up 28% from $11.2B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Brevan Howard Capital Management deployed $1.99B of net new capital in Q3 2024, opening 483 new positions and adding to 305 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 2,136,000 shares worth $98M.

By sector, the portfolio is most concentrated in Technology at 2.5% of assets, up from 2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was UnitedHealth, an estimated $21.4M trimmed.

  • Brevan Howard Capital Management's largest Q3 2024 buy was iShares MSCI Emerging Markets ETF: 2,136,000 shares worth $98M.
  • Brevan Howard Capital Management added most to Eli Lilly in Q3 2024, an estimated $27.2M increase.
  • Brevan Howard Capital Management's biggest Q3 2024 reduction was UnitedHealth, cutting an estimated $21.4M.
  • Brevan Howard Capital Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2024, selling an estimated $59M.
  • Brevan Howard Capital Management's ten largest holdings make up 75% of its $14.4B portfolio in Q3 2024.
  • Brevan Howard Capital Management opened 483 new positions and closed 405 in Q3 2024.
  • Brevan Howard Capital Management's portfolio value rose 28% quarter-over-quarter to $14.4B.

Based on Brevan Howard Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.